Emergent BioSolutions Inc. (EBS)

NYSE: EBS · Real-Time Price · USD

Compare

11.03

-0.01 (-0.09%)

At close: Feb 11, 2026, 4:00 PM EST

11.13

+0.10 (0.91%)

Pre-market: Feb 12, 2026, 7:30 AM EST

Emergent BioSolutions Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	245.5	99.5	111.7	642.6	576.1	621.3
Trading Asset Securities	-	-	-	8.5	-	-
Cash & Short-Term Investments	245.5	99.5	111.7	651.1	576.1	621.3
Cash Growth	63.78%	-10.92%	-82.84%	13.02%	-7.27%	270.26%
Accounts Receivable	149.5	154.5	191	159.2	278.9	230.9
Receivables	149.5	154.5	191	159.2	278.9	230.9
Inventory	356.3	311.7	328.9	350.7	344.5	307
Prepaid Expenses	25.6	26.9	47.9	49.4	68.2	34.5
Restricted Cash	3.7	6.1	-	-	0.2	0.2
Other Current Assets	6.3	-	-	-	2	2
Total Current Assets	786.9	598.7	679.5	1,210	1,270	1,196
Property, Plant & Equipment	217	282.3	399	837	828.4	675.1
Goodwill	-	-	-	218.2	224.9	266.7
Other Intangible Assets	452.7	501.5	566.6	728.8	604.6	663.1
Long-Term Deferred Charges	-	-	-	-	1.6	44.6
Other Long-Term Assets	4.4	7.2	178.1	171.9	28.3	37.8
Total Assets	1,461	1,390	1,823	3,166	2,958	2,883
Accounts Payable	57.4	60.9	112.2	103.5	128.9	136.1
Accrued Expenses	50.5	73.8	92.7	122.2	140.4	131.5
Current Portion of Long-Term Debt	-	-	413.7	957.3	36.1	39.5
Current Portion of Leases	1.8	2.7	3.5	5.8	5.8	5.4
Current Unearned Revenue	6.1	4.8	27.2	26.4	11.7	44.6
Other Current Liabilities	20.7	20.2	2	13.7	51.1	27.4
Total Current Liabilities	136.5	162.4	651.3	1,229	374	384.5
Long-Term Debt	663.1	663.7	446.5	448.5	811	850.3
Long-Term Leases	6.1	9.7	13.8	14.8	24.2	27.8
Long-Term Unearned Revenue	-	-	-	-	-	55.5
Long-Term Deferred Tax Liabilities	36.3	41.7	47.2	59.7	93.3	53.2
Other Long-Term Liabilities	36.5	29.4	15.1	26.7	43.7	64.9
Total Liabilities	878.5	906.9	1,174	1,779	1,346	1,436
Common Stock	0.1	0.1	0.1	0.1	0.1	0.1
Additional Paid-In Capital	938.6	928	904.4	873.5	829.4	784.9
Retained Earnings	-105.2	-212.4	-21.8	738.7	950.3	726.9
Treasury Stock	-243.5	-227.7	-227.7	-227.7	-152.2	-39.6
Comprehensive Income & Other	-7.5	-5.2	-5.7	3.1	-16.1	-25.3
Shareholders' Equity	582.5	482.8	649.3	1,388	1,612	1,447
Total Liabilities & Equity	1,461	1,390	1,823	3,166	2,958	2,883
Total Debt	671	676.1	877.5	1,426	877.1	923
Net Cash (Debt)	-425.5	-576.6	-765.8	-775.3	-301	-301.7
Net Cash Per Share	-7.59	-10.88	-14.96	-15.48	-5.56	-5.61
Filing Date Shares Outstanding	52.52	54.34	52.2	50.14	50.5	53.3
Total Common Shares Outstanding	52.7	54.33	52.2	50.1	51.3	53.1
Working Capital	650.4	436.3	28.2	-18.5	895.9	811.4
Book Value Per Share	11.05	8.89	12.44	27.70	31.41	27.25
Tangible Book Value	129.8	-18.7	82.7	440.7	782	517.2
Tangible Book Value Per Share	2.46	-0.34	1.58	8.80	15.24	9.74
Land	20.7	25.8	30	54.9	52.1	52.7
Buildings	159.4	196.1	229.9	327.9	269.7	246.3
Machinery	252.9	368.3	433.6	567.5	513.5	362.1
Construction In Progress	5.3	10.3	36.7	185.5	223.2	183.4

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q